The brain-computer interface (BCI) market is undergoing a transformation, with companies like Neuralink and Blackrock Neurotech investing heavily in surgically implanted devices. However, a groundbreaking startup, Subsense, is taking a different path. With $17 million in seed funding, Subsense aims to pioneer the first noninvasive, nanoparticle-based BCI, eliminating the need for risky neurosurgery. Musumeci Online…